| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.2M | +5.0% |
| Cost of Revenue | $3.4M | -14.9% |
| R&D Expense | $98.4M | +26.4% |
| SG&A Expense | $32.4M | +29.0% |
| Operating Income | -$97.4M | -8.4% |
| Pre-tax Income | -$88.8M | -2.2% |
| Income Tax | -$367K | — |
| Net Income | -$88.5M | -1.8% |
| EPS (Basic) | -$1.27 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.9M | -11.9% |
| Accounts Receivable | $298K | -38.4% |
| Current Assets | $128.9M | -44.4% |
| Total Assets | $197.4M | -22.5% |
| Current Liabilities | $31.0M | +41.1% |
| Total Liabilities | $40.2M | -29.4% |
| Stockholders' Equity | $157.2M | -20.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.3M | -15.9% |
| Capital Expenditures | $1.3M | +116.4% |
| Investing Cash Flow | $46.2M | +266.0% |
| Financing Cash Flow | $26.7M | -63.3% |
| Free Cash Flow | -$79.6M | -16.8% |
| +4.5% |
| EPS (Diluted) | -$1.27 | +4.5% |